These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8678906)

  • 1. Differential effects of tenidap on the zymosan- and lipopolysaccharide-induced expression of mRNA for proinflammatory cytokines in macrophages.
    Bondeson J; Sundler R
    Biochem Pharmacol; 1996 Jul; 52(1):35-42. PubMed ID: 8678906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis.
    Otterness IG; Bliven ML; Downs JT; Natoli EJ; Hanson DC
    Cytokine; 1991 Jul; 3(4):277-83. PubMed ID: 1873477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tenidap on Ca(2+)- and protein kinase C-mediated protein phosphorylation, activation of the arachidonate-mobilizing phospholipase A2 and subsequent eicosanoid formation in macrophages.
    Bondeson J; Sundler R
    Biochem Pharmacol; 1994 Sep; 48(6):1171-9. PubMed ID: 7945411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines: a review.
    Bondeson J
    Gen Pharmacol; 1996 Sep; 27(6):943-56. PubMed ID: 8909974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent.
    McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages.
    Bondeson J; Sundler R
    Biochem Pharmacol; 1995 Nov; 50(11):1753-9. PubMed ID: 8615853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
    Palacios I; Lopez-Armada MJ; Hernandez P; Sanchez-Pernaute O; Gutierrez S; Miguelez R; Martinez J; Egido J; Herrero-Beaumont G
    Clin Exp Immunol; 1998 Mar; 111(3):588-96. PubMed ID: 9528904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA.
    Takasuka N; Tokunaga T; Akagawa KS
    J Immunol; 1991 Jun; 146(11):3824-30. PubMed ID: 1903414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
    Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
    J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effects of 7-hydroxyl-1-methylindole-3-acetonitrile, a synthetic arvelexin derivative, on the macrophages through destabilizing mPGES-1 mRNA and suppressing NF-κB activation.
    Shin JS; Choi HE; Kim SD; Lee YS; Cho YW; Lee KT
    Chem Biol Interact; 2014 Dec; 224():68-77. PubMed ID: 25451575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response.
    Sipe JD; Bartle LM; Loose LD
    J Immunol; 1992 Jan; 148(2):480-4. PubMed ID: 1729367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
    Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
    J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of interleukin-6 expression in a human astrocytoma cell line by tenidap.
    Lieb K; Fiebich BL; Hüll M; Berger M; Bauer J
    Cell Tissue Res; 1997 May; 288(2):251-7. PubMed ID: 9082960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line.
    Golding S; Emery P; Young SP
    J Immunol; 1995 May; 154(10):5384-90. PubMed ID: 7730639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenidap, but not nonsteroidal anti-inflammatory drugs, inhibits T-cell proliferation and cytokine induction.
    Dolhain RJ; de Kuiper P; Verweij CL; Penders JM; Breedveld FC; Dijkmans BA; Miltenburg AM
    Scand J Immunol; 1995 Dec; 42(6):686-93. PubMed ID: 8552993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenidap enhances P2Z/P2X7 receptor signalling in macrophages.
    Sanz JM; Chiozzi P; Di Virgilio F
    Eur J Pharmacol; 1998 Aug; 355(2-3):235-44. PubMed ID: 9760038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages.
    Schaloske RH; Provins JW; Kessen UA; Dennis EA
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):64-75. PubMed ID: 15708354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.